A CLOSER READING OF SKINCARERESEARCHED OCTOBER 2026
ThePrescription Skincare.
Advertising disclosure: CoreAge Rx is our featured commercial partner and appears first. Placement is promotional; it is not a clinical superiority ranking. How we are funded
Retail retinaldehyde comparison

Medik8 Crystal Retinal review

This nonprescription retinaldehyde range provides a cosmetic comparison with tretinoin. Variant identity and the exact study claim matter more than a broad vitamin-A label.

Crystal Retinal enters this prescription-focused publication as an explicitly labeled retail comparison. It contains retinaldehyde, which should not be described as the same preparation as a tretinoin prescription. The different numbered versions make it especially important to attach a claim or price to the exact formula under consideration.

We read Medik8’s US listing, direct refund policy and AAD context on October 14, 2026. The review includes no product trial, medical consultation or completed purchase. It examines the limits of the seller’s published evidence and explains why a cosmetic strength ladder does not provide a prescription-substitution rule.

Medik8 Crystal Retinal: Retinaldehyde variants, 33-person study: version 6, No tretinoin dose conversion
Editorial diagram of the documented facts. No product-use test or patient result is depicted.
Access
Retail cosmetic comparison
Ingredient
Retinaldehyde, not tretinoin
Variants
0.01%–0.24% retinaldehyde
Displayed offer
$56 on the range page; exact selection requires confirmation
Evidence limit
Metabolic research and a variant-specific clinical summary answer different questions

The numbered range identifies separate retinaldehyde strengths

Crystal Retinal 1, 3, 6, 10, 20 and 24 correspond to declared retinaldehyde concentrations of 0.01%, 0.03%, 0.06%, 0.1%, 0.2% and 0.24%. Those numbers belong to this range, not to a conversion table for retinol or tretinoin. [1]

A higher number does not establish that a version is more suitable for a particular reader. We do not prescribe progression through the range. The formula guide provides the related principle: identify the molecule and vehicle before trying to compare percentages across preparations.

Separate ingredient lists matter to a formula comparison

The manufacturer provides declarations for the individual variants. Their broader moisturizing bases and supporting materials are part of the finished preparation. A claim about an isolated molecule in another vehicle cannot automatically establish the outcome or tolerance of a chosen Crystal Retinal tube. [1]

The no-artificial-fragrance wording should also be read narrowly. The declarations include materials such as vanilla or tonka-related extracts and coumarin; that wording is not a universal fragrance-free or sensitivity guarantee. We have no firsthand assessment of skin feel, residue, layering or irritation from any version.

The biochemical multiplier is not a clinical timetable

The 11-times claim refers to biochemical research from 1990 concerning retinol and retinal metabolism. It is not a head-to-head clinical trial showing that today’s Crystal Retinal preparation delivers a personal cosmetic result eleven times faster than tretinoin or another finished product. [1]

The manufacturer also describes a separate 33-person, twelve-week study of Crystal Retinal 6. Those observations belong to that specific version and study account. The complete report and comparison conditions were not independently appraised here. A shorter before-and-after caption must not silently move the twelve-week findings to an earlier date.

Cosmetic evidence does not establish a prescription replacement

The Obagi tretinoin review concerns a prescription acne preparation. Crystal Retinal’s appearance-study summary does not prove that it shares that treatment indication, delivers an equivalent dose or belongs alongside it in every routine. The ingredient-family relationship is not enough to establish those conclusions.

AAD retinoid guidance provides context for questions about irritation and the actual preparation. This publication does not instruct readers to combine products or move up a strength ladder. Relevant medical circumstances, including pregnancy or breastfeeding, and existing prescriptions warrant an appropriate professional discussion rather than an assumption based on retail access. [3]

The displayed price must be matched to the selected version

The captured US range page displayed $56 alongside multiple variants and availability-notification language. That does not establish one current price or stock status for every version. The selected strength, package and purchase terms should be confirmed before treating the amount as a meaningful comparison. [1]

Companion moisturizers, peptide serums and eye products are separate purchases unless an actual bundle includes them. A seller’s uses-per-tube description also does not establish a personal treatment duration. The cost guide helps keep the chosen charge apart from assumptions about supply and use.

The US return policy has specific conditions

The direct policy describes a 30-day period from purchase and requires authorization. Eligible used returns must retain at least half the contents, while a kit must be returned with its components together. Those conditions are more precise than an unrestricted invitation to finish a tube and claim a refund. [2]

A different national store or retailer may apply different rules. We did not test customer service, delivery or reimbursement, so the policy establishes only the seller’s written terms. Confirm which date starts the window and which order is covered before relying on a short satisfaction claim.

The decision remains formula-specific

Variant declarations and identifiable study footnotes are useful disclosures. Their limits matter equally: the metabolic multiplier is not a result timetable, one study does not cover every concentration, and the displayed starting price is not a verified universal offer. This review has no personal-wear verdict to add.

CoreAge Rx is a separately disclosed commercial feature. Its placement does not prove equivalent ingredients, exposure or clinical superiority. The next useful records are the selected package label, relevant full study report and complete order agreement, together with professional guidance where treatment questions are involved. AAD new-product advice supplies general context without certifying this formula. [4]

THE RESEARCH

Sources & further reading

Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.

  1. Crystal Retinal | Anti-Aging Retinal Serum | Medik8 US – Medik8-USOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
  2. Refund policy – Medik8-USOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
  3. American Academy of Dermatology — Retinoid or retinol?Dermatology guidance on retinoids, irritation and pregnancy · Checked October 14, 2026
  4. How to test skin care productsIndependent clinical or regulatory context · Checked October 14, 2026

Keep reading